ExoCellular Diagnostics

Revolutionizing Cancer Diagnostics

Blood tests for early cancer detection and disease monitoring


Introducing ExoCellular Diagnostics ('EDx')

We are a pioneering biotechnology company specializing in liquid biopsy-based cancer diagnostic tests.

With headquarters in Cambridge, Massachusetts, USA and facilities in Munich, Germany, we are committed to developing and commercializing innovative liquid biopsy-based tests for cancer detection/diagnosis and disease monitoring.

Advanced Diagnostic Innovation

Our Technology Solutions


Hsp70-based liquid biopsy for cancer detection and monitoring

Prostate Cancer

Improving the diagnosis of early prostate cancer


Innovative approach for isolating circulating tumor cells

Engage with ExoCellular Diagnostics

Join us in transforming the world of cancer diagnostics. Contact us today to learn more about our innovative liquid biopsy tests.